RA
MDT icon

Resolute Advisors’s Medtronic MDT Stock Holding History

Resolute Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-338
Closed -$43K – 392
2021
Q3 		$43K Hold
338
– – 0.01% 132
2021
Q2 		$42K Hold
338
– – 0.01% 100
2021
Q1 		$26K Buy
+338
New +$39.6K ﹤0.01% 116

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Resolute Advisors's MDT Position: Q4 2021 in Review

Resolute Advisors sold out of Medtronic (MDT) in Q4 2021, closing a stake of 338 shares — an estimated $43K sold.

Resolute Advisors first reported a position in MDT in Q1 2021 and held it in 3 quarters. The position peaked at $43K in Q3 2021. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Resolute Advisors reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Resolute Advisors sold 338 Medtronic shares in Q4 2021, an estimated $43K.
  • Resolute Advisors first reported a position in Medtronic in Q1 2021 and held it in 3 quarters.
  • Resolute Advisors's Medtronic position peaked at $43K in Q3 2021.
  • 2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Resolute Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.